Peri-Implantitis - Global Strategic Business Report

The global market for Peri-Implantitis was valued at US$1.1 Billion in 2025 and is projected to reach US$1.7 Billion by 2032, growing at a CAGR of 7.1% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Peri-Implantitis Market - Key Trends & Drivers Summarized

What Is Peri-Implantitis and Why Is It Emerging as a Dental Health Concern?

Peri-implantitis is a progressive inflammatory condition affecting soft and hard tissues around dental implants, leading to bone loss and potential implant failure. It typically develops from poor plaque control, mechanical overload, or systemic health factors such as diabetes or smoking. As dental implants become more widespread, peri-implantitis is being increasingly recognized as a significant complication requiring timely diagnosis and intervention.

Unlike peri-implant mucositis, which is confined to soft tissue inflammation, peri-implantitis involves irreversible bone damage. This condition can result in pain, implant mobility, and even loss of the implant. As implant procedures rise globally in both restorative and cosmetic dentistry, awareness and clinical management of peri-implantitis are becoming critical to maintaining long-term success rates.

How Are Diagnosis and Treatment Modalities Evolving in Clinical Practice?

Diagnosis is based on clinical assessment of inflammation, bleeding on probing, increased pocket depth, and radiographic bone loss. Advances in diagnostic tools, including digital imaging, 3D cone-beam computed tomography, and peri-implant tissue biomarkers, are enabling earlier and more accurate detection. Standardized diagnostic protocols are also being developed to differentiate peri-implantitis from other inflammatory conditions.

Treatment options include mechanical debridement, antiseptic irrigation, systemic or local antibiotics, and surgical intervention such as guided bone regeneration or implant surface decontamination. Emerging therapies include laser-assisted debridement, photodynamic therapy, and biologic agents to promote bone healing. Implant design and surface coatings are being modified to reduce biofilm adhesion and enhance tissue integration, thus lowering risk of recurrence.

Where Is Clinical Demand Increasing and Which Stakeholders Are Focusing on Solutions?

Dental clinics, periodontists, and implantology centers are the primary settings for managing peri-implantitis. Demand is rising in both developed and emerging markets due to greater use of implants in aging populations, aesthetic dentistry, and full-arch rehabilitation. Patients with risk factors such as poor oral hygiene, history of periodontitis, or smoking are more likely to develop complications, prompting clinicians to adopt preventive and early-intervention strategies.

Dental device manufacturers, biomaterials developers, and oral hygiene product companies are investing in innovations to address peri-implantitis. Academic research is also expanding into regenerative therapies and biofilm control strategies. Integration of digital health records and regular implant maintenance programs is helping dental professionals monitor implant health more closely and reduce the burden of late-stage peri-implant disease.

Growth in the Peri-Implantitis market is driven by several factors

Growth in the peri-implantitis market is driven by factors such as rising global prevalence of dental implants, increased recognition of implant-related complications, and evolving standards in oral healthcare. Demand for advanced diagnostics, effective treatment protocols, and implant maintenance solutions is increasing among dental professionals seeking to preserve implant longevity.

Technological improvements in surgical techniques, implant surface modification, and non-invasive therapies are broadening clinical options for intervention. Regulatory emphasis on implant safety and post-market surveillance is also promoting investment in peri-implantitis prevention and management tools. With the aging population and growing use of implant-supported prosthetics, peri-implantitis management is becoming a vital segment within periodontal and restorative dentistry.

Report Scope

The report analyzes the Peri-Implantitis market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:

• Segments: Type (Non-Surgical Type, Surgical Type); End-Use (Dental Clinics End-Use, Hospitals End-Use)
• Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Non-Surgical Type segment, which is expected to reach US$953.6 Million by 2032 with a CAGR of a 5.7%. The Surgical Type segment is also set to grow at 9.1% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, valued at $292.3 Million in 2025, and China, forecasted to grow at an impressive 10.6% CAGR to reach $365.4 Million by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Peri-Implantitis Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Peri-Implantitis Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Peri-Implantitis Market expected to evolve by 2032?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2032?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of players such as 3M, Alpha-Bio Tec, BioHorizons, Biomatlante, CAMLOG Biotechnologies and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Peri-Implantitis market report include:

• 3M
• Alpha-Bio Tec
• BioHorizons
• Biomatlante
• CAMLOG Biotechnologies
• DENTSPLY SIRONA
• Geistlich Pharma
• Hiossen Implant
• Institut Straumann AG
• Keystone Dental
• Medentika
• MegaGen Implant
• MIS Implants Technologies
• Neobiotech
• Nobel Biocare
• Osstem Implant
• PARADENT Dental
• Southern Implants
• Thommen Medical
• ZimVie

What Sets This Report Apart From Others?

• Grounded in Domain Expert Perspectives: Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.
• Captures Early Market Signals: Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.
• Draws From a Broad, Validated Intelligence Base: Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.
• Connects Signals With Strategic Market Direction: Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.
• Provides In-Depth Company Intelligence: Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.
• Market Share Is Examined Where It Matters: A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, the report extends market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.